References
1. Bearak J, Popinchalk A, Ganatra B, Moller A-B, Tunçalp Ö, Beavin C,
et al. Unintended pregnancy and abortion by income, region, and the
legal status of abortion: estimates from a comprehensive model for
1990-2019. The Lancet Global Health. 2020.
2. Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B, et
al. Abortion incidence between 1990 and 2014: global, regional, and
subregional levels and trends. Lancet. 2016;388(10041):258-67.
3. Regan L, Glasier A. The British 1967 Abortion Act-still fit for
purpose? Lancet. 2017;390(10106):1936-7.
4. National Institute for Health and Care Excellence (NICE). Abortion
care. Evidence Review A - Accessibility and sustainability of abortion
services. London; 2019 9/2019.
5. O’Shea LE, Hawkins JE, Lord J, Schmidt-Hansen M, Hasler E, Cameron S,
et al. Access to and sustainability of abortion services: a systematic
review and meta-analysis for the National Institute of Health and Care
Excellence—new clinical guidelines for England. Human Reproduction
Update. 2020.
6. WHO Global Observatory for eHealth. Telemedicine: opportunities and
developments in Member States: report on the second global survey on
eHealth. Geneva: World Health Organization; 2010.
7. Dorsey ER, Topol EJ. Telemedicine 2020 and the next decade. The
Lancet. 2020;395(10227):859.
8. Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R,
Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic
review. BJOG. 2019;126(9):1094-102.
9. Royal College of Obstetricians and Gynaecologists (RCOG), Royal
College of Midwives (RCM), Faculty of Sexual & Reproductive Healthcare
(FSRH), British Society of Abortion Care Providers (BSACP). Coronavirus
(COVID-19) infection and abortion care. London, UK: Royal College of
Obstetricians and Gynaecologists; 2020 31/07/2020.
10. Department of Health & Social Care (DHSC). The Abortion Act 1967 -
Approval of a Class of Places. London: English Government; 2020.
11. Scottish Government. Abortion – Covid-19 – Approval For
Mifepristone to be Taken At Home and Other Contingency Measures.
Edinburgh: Scottish Government; 2020.
12. Welsh Government. The Abortion Act 1967 – Approval of a Class of
Place for Treatment for the Termination of Pregnancy (Wales) 2020. In:
Government W, editor. Cardiff: Welsh Government; 2020.
13. Aiken ARA, Guthrie KA, Schellekens M, Trussell J, Gomperts R.
Barriers to accessing abortion services and perspectives on using
mifepristone and misoprostol at home in Great Britain. Contraception.
2018;97(2):177-83.
14. Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the
MARE guidelines. Contraception. 2016;94(2):97-103.
15. Royal College of Obstetricians and Gynaecologists (RCOG). Decision
aid for early medical abortion without ultrasound. London: Royal College
of Obstetricians and Gynaecologists (RCOG), ; 2020.
16. National Institute for Health and Care Excellence (NICE). Abortion
Care. London; 2019 9/25/2019. Report No.: NG140.
17. Royal College of Obstetricians and Gynaecologists (RCOG), Faculty of
Sexual & Reproductive Healthcare (FSRH), British Society of Abortion
Care Providers (BSACP). Clinical Guidelines for Early Medical Abortion
at Home - England. London; 2019 1/3/2019.
18. Erlank CP, Lord J, Church K. Early medical abortion using
telemedicine – acceptability to patients [preprint]. MedRxiv.
2020:2020.11.11.20229377.
19. Meurice M, Whitehouse K, Blaylock R, Chang J, P L. Client
satisfaction and experience of home use of mifepristone and misoprostol
for medical abortion up to 10 weeks’ gestation at British Pregnancy
Advisory Service: a cross-sectional evaluation [preprint]. .
Authorea. 2020.
20. Ge M, Durham LK, Meyer RD, Xie W, Thomas N. Covariate-Adjusted
Difference in Proportions from Clinical Trials Using Logistic Regression
and Weighted Risk Differences. Drug information journal : DIJ / Drug
Information Association. 2011;45(4):481-93.
21. Department of Health & Social Care (DHSC). Abortion statistics
during COVID-19: data tables. In: Department of Health & Social Care
(DHSC), editor. London: UK Government; 2020.
22. Aiken ARA, Starling JE, Gomperts R, Scott JG, Aiken C. Demand for
Self-Managed Online Telemedicine Abortion in Eight European Countries
During the COVID-19 Pandemic: A Regression Discontinuity Analysis
[preprint]. MedRxiv. 2020:2020.09.15.20195222.
23. Upadhyay UD, Desai S, Zlidar V, Weitz TA, Grossman D, Anderson P, et
al. Incidence of emergency department visits and complications after
abortion. Obstet Gynecol. 2015;125(1):175-83.
24. Centers for Disease Control and Prevention (CDC). Ectopic
pregnancy—United States, 1990–1992. MMWR Morb Mortal Wkly Rep.
1995;44(46–8):46–8.
25. National Institute for Health and Care Excellence (NICE). Ectopic
pregnancy and miscarriage: diagnosis and initial management. London;
2019 4/17/2019. Report No.: NG126.
26. Shannon C, Brothers LP, Philip NM, Winikoff B. Ectopic pregnancy and
medical abortion. Obstet Gynecol. 2004;104:161–7.
27. Mol BW, van der Veen F, Bossuyt PM. Symptom-free women at increased
risk of ectopic pregnancy: should we screen? Acta Obstet Gynecol Scand.
2002;81(7):661-72.
28. Clark WH, Gold M, Grossman D, Winikoff B. Can mifepristone medical
abortion be simplified? A review of the evidence and questions for
future research. Contraception. 2007;75(4):245-50.
29. Bracken H, Clark W, Lichtenberg ES, Schweikert SM, Tanenhaus J,
Barajas A, et al. Alternatives to routine ultrasound for eligibility
assessment prior to early termination of pregnancy with
mifepristone-misoprostol. BJOG. 2011;118(1):17-23.
30. Raymond EG, Grossman D, Mark A, Upadhyay UD, Dean G, Creinin MD, et
al. Commentary: No-test medication abortion: A sample protocol for
increasing access during a pandemic and beyond. Contraception. 2020.
31. Harris LH, Grossman D. Complications of Unsafe and Self-Managed
Abortion. N Engl J Med. 2020;382(11):1029-40.